Skip to main content

Centene Value Stock - Dividend - Research Selection

Centene

ISIN: US15135B1017 , WKN: 766458

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. It operates through two segments, Managed Care and Specialty Services. The Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children\'s health insurance program, long-term care, foster care, and dual eligible individual, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray services, home-based primary care, transportation assistance, vision care, dental care, immunizations, prescriptions and limited over-the-counter drugs, specialty pharmacy, therapies, social work services, and care coordination. The Specialty Services segment provides pharmacy benefits management services; health, triage, wellness, and disease management services; vision and dental services; correctional healthcare services; home based primary care services; and integrated long-term care services, as well as care management software that automate the clinical, administrative, and technical components of care management programs. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, military service members and their families, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Home State Health and Centene Foundation Launch Medical Respite Program in St. Louis

2026-04-20
Home State Health, a leading health insurer providing quality, affordable coverage to Missourians, and the Centene Foundation ("the Foundation"), the philanthropic arm of Centene Corporation (NYSE: CNC), today announced a $225,000 grant to Three Steps Home, formerly Bridge of Hope Ministries, to support the launch of St. Louis' first dedicated short-term residential, post-acute medical recuperative care program for individuals experiencing homelessness.

Honeywell Gears Up to Post Q1 Earnings: What Lies Ahead for the Stock?

2026-04-20
HON gears up for Q1 2026 results as aerospace strength and acquisitions offset segment weakness and cost pressures ahead of the April 23 release.

SAP's Q1 Earnings Loom: Will Cloud Backlogs & Deal Wins Fuel Upside?

2026-04-20
SAP's Q1 2026 earnings lean on cloud growth and AI momentum, but trade tensions, slower backlog growth and deal timing may hurt it.

Jefferies Maintains Hold on Centene, Raises Price Target to $39

2026-04-20
Jefferies analyst David Windley maintains Centene (NYSE:CNC) with a Hold and raises the price target from $37 to $39.

Centene Corporation (CNC): David Einhorn Is Loading Up On This Stock

2026-04-19
Centene Corporation (NYSE:CNC) is featured on the David Einhorn Stock Portfolio: Top 10 Stock Picks. Centene Corporation (NYSE:CNC) first appeared in the 13F portfolio of Greenlight Capital in the first quarter of 2020. This holding comprised 204,000 shares and was sold off within the next few months. A new position was then opened in the […]

Centene Housing Investment And New Leaders Aim To Steady Core Programs

2026-04-18
Centene subsidiary Health Net is committing $3 million to support affordable and supportive housing projects in the Sacramento region. Centene is also adding two new executive leadership roles aimed at strengthening oversight across Medicaid, Medicare, and commercial operations. For investors tracking NYSE:CNC, these moves come as the shares trade at $38.17, with a 5.6% return over the past 30 days and a 2.3% return over the past week. Over longer horizons, returns have been weaker,...

Will Declining Premiums & Higher MCR Weigh on MOH Q1 Earnings?

2026-04-17
Molina Healthcare heads into Q1 earnings with falling estimates, weak membership trends, and rising MCR, casting doubt on a potential earnings beat.

3M Gears Up to Report Q1 Earnings: What's in the Offing?

2026-04-17
MMM heads into Q1 earnings with revenue and EPS growth expected, backed by strong industrial demand but weighed down by Consumer segment weakness.

2 S&P 500 Stocks with Competitive Advantages and 1 That Underwhelm

2026-04-16
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.

Danaher Gears Up to Post Q1 Earnings: What Lies Ahead for the Stock?

2026-04-16
DHR heads into Q1 results with rising bioprocessing demand and steady estimates, but cost pressures and FX headwinds could weigh on performance.